Skip to content

Study on the Role and Mechanism of Increased Inflammatory Levels Induced by Complement C3/CR3 in Depression of Parkinson's Disease

Study on the Role and Mechanism of Increased Inflammatory Levels Induced by Complement C3/CR3 in Depression of Parkinson's Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108615
Enrollment
Unknown
Registered
2025-09-02
Start date
2025-09-23
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression in Parkinson's disease.

Interventions

Observation group:NA

Sponsors

Huzhou Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: The age range is between 45 and 75 years old, including the critical value, and meets the following criteria: 1. Parkinson's disease group: Patients meet the diagnostic criteria for Parkinson's disease in the British Parkinson's Disease Brain Bank and the diagnostic criteria for non-depression in DSM-IV;All patients with Parkinson's disease receive regular treatment and take anti-Parkinson's drugs stably. 2.Parkinson's disease with depression group: Patients met the diagnostic criteria for Parkinson's disease in the British Parkinson's Disease Brain Bank and the diagnostic criteria for depression in DSM-IV. Parkinson's disease patients were scored using the Hamilton Depression Scale (HAMD), with a score of >=7 as the inclusion criterion. All Parkinson's disease patients received regular treatment and took anti-Parkinson's drugs stably. 3.Simple depression group: Patients met the diagnostic criteria for depression in DSM-IV;The subjects were scored using the Hamilton Depression Scale (HAMD), with a score of >=7 as the inclusion criterion. 4.Healthy control group: No diagnosis of Parkinson's disease, depression or inflammatory diseases in the past year.

Exclusion criteria

Exclusion criteria: 1.After a head CT or MRI scan, it was diagnosed as Parkinson's syndrome caused by chemical drugs, poisoning, trauma and other etiologies. Combined with severe cognitive and mental disorders, taking other antipsychotic drugs at the same time; 2.Those with major diseases of the heart, brain, kidneys or other systems; 3.Those who have participated in other clinical trials within the last three months; 4.Those who are unable to cooperate in completing project checks and scales.

Design outcomes

Primary

MeasureTime frame
Complement;

Countries

China

Contacts

Public ContactYang Li

Huzhou Center Hospital

li15850202894@126.com+86 18268278782

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026